Literature DB >> 1383219

Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity.

W H Miller1, S M Daluge, E P Garvey, S Hopkins, J E Reardon, F L Boyd, R L Miller.   

Abstract

Two enantiomers of carbovir, a carbocyclic analog of 2',3'-dideoxyguanosine, were compared with respect to their phosphorylation and the phosphorylation of their nucleotides by mammalian enzymes. 5'-Nucleotidase catalyzed the phosphorylation of (-)-carbovir, which is active against HIV (human immunodeficiency virus), but did not phosphorylate (+)-carbovir. (-)-Carbovir monophosphate was 7,000 times more efficient as a substrate for GMP kinase than was (+)-carbovir monophosphate. Pyruvate kinase, phosphoglycerate kinase, and creatine kinase phosphorylated both enantiomers of carbovir diphosphate at similar rates. Nucleoside-diphosphate kinase preferentially phosphorylated the (-)-enantiomer. Both enantiomers of carbovir triphosphate were substrates and alternative substrate inhibitors of HIV reverse transcriptase. Thus, the contrasting HIV-inhibitory activities of carbovir enantiomers were due to differential phosphorylation by cellular enzymes and not due to enantioselectivity of HIV reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383219

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase.

Authors:  Chengwei Li; Brian G Gentry; John C Drach; Jiri Zemlicka
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-09       Impact factor: 1.381

2.  Enzyme closure and nucleotide binding structurally lock guanylate kinase.

Authors:  Olivier Delalande; Sophie Sacquin-Mora; Marc Baaden
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

3.  The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels.

Authors:  R C Tam; K Ramasamy; J Bard; B Pai; C Lim; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase.

Authors:  L L Bennett; P W Allan; G Arnett; Y F Shealy; D S Shewach; W S Mason; I Fourel; W B Parker
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Solution structure and functional investigation of human guanylate kinase reveals allosteric networking and a crucial role for the enzyme in cancer.

Authors:  Nazimuddin Khan; Parag P Shah; David Ban; Pablo Trigo-Mouriño; Marta G Carneiro; Lynn DeLeeuw; William L Dean; John O Trent; Levi J Beverly; Manfred Konrad; Donghan Lee; T Michael Sabo
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

6.  1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Authors:  S M Daluge; S S Good; M B Faletto; W H Miller; M H St Clair; L R Boone; M Tisdale; N R Parry; J E Reardon; R E Dornsife; D R Averett; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.

Authors:  M B Faletto; W H Miller; E P Garvey; M H St Clair; S M Daluge; S S Good
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

8.  Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.

Authors:  Sanjay U C Sankatsing; Patrick G Hoggard; Alwin D R Huitema; Rolf W Sparidans; Stephen Kewn; Kristel M L Crommentuyn; Joep M A Lange; Jos H Beijnen; David J Back; Jan M Prins
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  The 5'-triphosphates of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine equally inhibit human immunodeficiency virus type 1 reverse transcriptase.

Authors:  J E Wilson; J L Martin; K Borroto-Esoda; S Hopkins; G Painter; D C Liotta; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  PharmGKB summary: abacavir pathway.

Authors:  Julia M Barbarino; Deanna L Kroetz; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-05       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.